Tower Research Capital (TRC)’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,537
| Closed | -$3.25K | – | 6202 |
|
|
2024
Q1 | $3.25K | Buy |
3,537
+1,258
| +55% | +$2.18K | ﹤0.01% | 4898 |
|
|
2023
Q4 | $4.67K | Buy |
2,279
+2,165
| +1,899% | +$5.61K | ﹤0.01% | 4932 |
|
|
2023
Q3 | $415 | Buy |
+114
| New | +$494 | ﹤0.01% | 5572 |
|
|
2022
Q4 | – | Sell |
-13
| Closed | – | – | 6931 |
|
|
2022
Q3 | $0 | Buy |
+13
| New | +$455 | ﹤0.01% | 6883 |
|
|
2022
Q2 | – | Sell |
-67
| Closed | -$9K | – | 6966 |
|
|
2022
Q1 | $9K | Buy |
67
+8
| +14% | +$1.17K | ﹤0.01% | 4540 |
|
|
2021
Q4 | $10K | Buy |
59
+33
| +127% | +$12.3K | ﹤0.01% | 4654 |
|
|
2021
Q3 | $13K | Sell |
26
-13
| -33% | -$6.03K | ﹤0.01% | 4122 |
|
|
2021
Q2 | $19K | Sell |
39
-57
| -59% | -$30.6K | ﹤0.01% | 3966 |
|
|
2021
Q1 | $49K | Buy |
96
+13
| +16% | +$6.71K | ﹤0.01% | 3152 |
|
|
2020
Q4 | $39K | Buy |
+83
| New | +$27.2K | ﹤0.01% | 3357 |
|
|
2020
Q3 | – | Sell |
-14
| Closed | -$3K | – | 5239 |
|
|
2020
Q2 | $3K | Buy |
14
+2
| +17% | +$333 | ﹤0.01% | 4452 |
|
|
2020
Q1 | $1K | Sell |
12
-60
| -83% | -$10.9K | ﹤0.01% | 2896 |
|
|
2019
Q4 | $13K | Buy |
72
+60
| +500% | +$7.75K | ﹤0.01% | 2220 |
|
|
2019
Q3 | $2K | Buy |
+12
| New | +$1.6K | ﹤0.01% | 3778 |
|
|
2019
Q2 | – | Sell |
-19
| Closed | -$3K | – | 4530 |
|
|
2019
Q1 | $3K | Sell |
19
-25
| -57% | -$4.28K | ﹤0.01% | 3344 |
|
|
2018
Q4 | $5K | Buy |
+44
| New | +$6.75K | ﹤0.01% | 2965 |
|
|
2018
Q3 | – | Sell |
-21
| Closed | -$14K | – | 4410 |
|
|
2018
Q2 | $14K | Buy |
+21
| New | +$15.7K | ﹤0.01% | 2635 |
|
|
2017
Q2 | – | Sell |
-97
| Closed | -$23K | – | 3676 |
|
|
2017
Q1 | $23K | Buy |
97
+95
| +4,750% | +$25.5K | ﹤0.01% | 1225 |
|
|
2016
Q4 | $1K | Sell |
2
-2
| -50% | -$476 | ﹤0.01% | 3692 |
|
|
2016
Q3 | $1K | Sell |
4
-20
| -83% | -$5.61K | ﹤0.01% | 3421 |
|
|
2016
Q2 | $9K | Buy |
24
+21
| +700% | +$22.9K | ﹤0.01% | 2953 |
|
|
2016
Q1 | $2K | Buy |
+3
| New | +$2.02K | ﹤0.01% | 3493 |
|
|
2015
Q3 | – | Sell |
-10
| Closed | -$7K | – | 5023 |
|
|
2015
Q2 | $7K | Buy |
10
+7
| +233% | +$7.46K | ﹤0.01% | 3028 |
|
|
2015
Q1 | $7K | Sell |
3
-35
| -92% | -$59.7K | ﹤0.01% | 3088 |
|
|
2014
Q4 | $38K | Buy |
38
+20
| +111% | +$21.4K | ﹤0.01% | 1198 |
|
|
2014
Q3 | $19K | Buy |
+18
| New | +$30.3K | ﹤0.01% | 2358 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 5099 |
|
|
2013
Q4 | – | Sell |
-15
| Closed | -$35.5K | – | 5040 |
|
|
2013
Q3 | $33K | Buy |
+15
| New | +$29K | ﹤0.01% | 2288 |
|
|
2013
Q2 | – | Hold |
0
| – | – | – | 3999 |
|
Other funds holding AMPE
Tower Research Capital (TRC)'s AMPE Position: Q2 2024 in Review
Tower Research Capital (TRC) sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2024, closing a stake of 3,537 shares — an estimated $3.25K sold.
Tower Research Capital (TRC) first reported a position in AMPE in Q3 2013 and held it in 27 quarters. The position peaked at $49K in Q1 2021. 6 funds tracked by Wall St. Rank hold AMPE as of Q2 2024.
- Tower Research Capital (TRC) reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2024 after selling out during the quarter.
- Tower Research Capital (TRC) sold 3,537 Ampio Pharmaceuticals Inc. shares in Q2 2024, an estimated $3.25K.
- Tower Research Capital (TRC) first reported a position in Ampio Pharmaceuticals Inc. in Q3 2013 and held it in 27 quarters.
- Tower Research Capital (TRC)'s Ampio Pharmaceuticals Inc. position peaked at $49K in Q1 2021.
- 6 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2024.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2024, filed 13 Aug 2024.